Skip to main content

Table 2 Patients’ characteristics including comparison of patients with or without any treatment limitation (PTL)

From: Patients’ treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections

Variable All patients (n = 526) No limitation (n = 300) Any limitation (n = 226) p-value
n % n % n %
Symptoms
 Cough 235 44.7 161 53.7 74 32.7 < 0.001
 Sputum 33 6.3 18 6.0 15 6.6 0.856
 Sore throat 13 2.5 12 4.0 1 0.4 0.009
 Fever/chills 278 52.9 169 56.3 109 48.2 0.078
 Diarrhoea 73 13.9 50 16.7 23 10.2 0.041
 Nausea 28 5.3 15 5.0 13 5.8 0.700
 Loss of appetite 70 13.3 31 10.3 39 17.3 0.027
 Fatigue 179 34 100 33.2 79 35.0 0.711
 Dyspnea 268 51 158 52.7 110 48.7 0.379
 Headache 58 11 52 17.3 6 2.7 < 0.001
 Loss of smell/taste 38 7.2 30 10.0 8 3.5 0.006
Comorbidity
 Systemic hypertension 266 50.6 117 39.0 149 65.9 < 0.001
 Diabetes mellitus 122 23.2 54 18 68 30.1 0.002
 Left-heart failure 157 29.8 58 19.3 99 43.8 < 0.001
 Coronary heart disease 95 18.1 41 13.7 54 23.9 0.003
 Atrial fibrillation 101 19.2 37 12.3 64 28.3 < 0.001
 Cardiovascular disease 216 41.1 83 27.7 133 58.8 < 0.001
 COPD 51 9.7 21 7.0 30 13.3 0.018
 Asthma 21 4.0 15 5.0 6 2.7 0.260
 Obstructive airway disease 66 12.5 34 11.3 32 14.2 0.354
 Lung fibrosis 9 1.7 6 2.0 3 1.3 0.739
 Autoimmune disorder 24 4.6 13 4.3 11 4.9 0.834
 Malignant disease 105 20 33 11.0 72 31.9 < 0.001
 Renal disease 127 24.1 39 13.0 88 38.9 < 0.001
 Hepatic disease 51 9.7 26 8.7 25 11.1 0.375
 Cerebrovascular disease 86 16.3 34 11.3 51 22.6 < 0.001
 Dementia 79 15.0 8 2.7 71 31.4 < 0.001
 PAD 37 7.0 14 4.7 23 10.2 0.016
 VTE 24 4.6 14 4.7 10 4.4 1.000
 Depression/psychiatric disease 87 16.5 41 13.7 46 20.4 0.044
 Other diseases 358 68.1 193 64.3 165 73.0 0.038
  1. Bold p-values represent statistical significance (< 0.05)
  2. Cardiovascular disease: At least one of the cardiac comorbidities (see text); COPD: Chronic obstructive pulmonary disease; Obstructive airway disease: At least one of the two comorbidities (see text); PAD: peripheral artery disease; VTE: venous thromboembolism